The American Society for Gastrointestinal Endoscopy recently released new clinical guidance on the screening for pancreatic cancer in people with genetic susceptibility (Gastrointest Endosc 2022 Feb 16. doi:10.1016/j.gie.2021.12.001). GEN’s Sarah Tilyou spoke with lead author Mandeep S. Sawhney, MD, MS, FASGE, a gastroenterologist at Beth Israel Deaconess Medical Center and an associate professor of medicine at Harvard Medical School, in Boston, about the impetus for the guidelines and what they mean to GI practice.
Trending
- How Guardant aims to expand cancer screening with a blood test (Medtech Dive)
- Endoscope manufacturer faces $1M lawsuit after demo explosion (Becker’s GI & Endoscopy)
- AI-Based Red Density Score Predicts Clinical Outcomes in Ulcerative Colitis (GI & Endoscopy News)
- Machine Learning Improves Accuracy of Inflammatory Bowel Disease Identification Beyond ICD-10 Codes (Houston Methodist)
- No Surprises Act payment dispute process booms to $22.4 billion cost in 4 years: study (Medical Economics)
- PENTAX Medical and MAGENTIQ EYE Expand Global Partnership to Advance AI-Assisted Colonoscopy Worldwide (PR Newswire)
- Following Their Own Advice? Medscape Gastroenterologist Mental Health & Well-Being Report 2026 (Medscape)
- In-person therapist-delivered hypnotherapy versus smartphone-based self-guided hypnotherapy in IBS: a multicentre three-armed randomised controlled trial (GUT)
